PARP1 and small cell lung carcinoma: For example, proteomic profiling of small cell lung cancer (SCLC) identified PARP1 as a therapeutic target [11, 14], despite the fact that PARP1 protein overexpression in SCLC is not associated with any known alterations at the DNA level (mutation, copy number gains/losses, fusions).